Table 1.
Patient Characteristic by Clostridioides difficile Disease Severity
| Baseline Characteristics | All Cases (N = 78) |
Disease Severity | |||
|---|---|---|---|---|---|
| Non-Severe (N = 51) | Severe (N = 10) |
Fulminant (N = 6) | Unknown (N = 11) | ||
| Age, mean y (SD) | 68.83 (11.35) | 68.23 (12.35) | 73.17 (8.54) | 70.64 (4.21) | 66.68 (10.31) |
| BMI, mean kg/m 2 (SD) | 28.06 (6.99) | 28.25 (6.77) | 25.88 (6.71) | 31.95 (8.42) | 26.85 (6.15) |
| Chemotherapy, no. (%) | 8 (10.26) | 7 (13.73) | 0 | 0 | 1 (9.09) |
| Abdominal surgery, no. (%) | 4 (5.13) | 1 (1.96) | 3 (30.0) | 0 | 0 |
| PPI use, no. (%) | 32 (41.03) | 20 (39.22) | 7 (70.0) | 2 (33.33) | 3 (27.27) |
| Antibiotics, no. (%) a | 37 (47.44) | 25 (49.02) | 6 (60.0) | 2 (33.33) | 4 (36.36) |
Note. BMI, body mass index; PPI, proton pump inhibitor.
a
Any antibiotic administered or prescribed for at least 3 days during the 30 days preceding C. difficile infection diagnosis.